Treatment for brain metastases: ASCO-SNO-ASTRO guideline
MA Vogelbaum, PD Brown, H Messersmith… - 2022 - academic.oup.com
Purpose To provide guidance to clinicians regarding therapy for patients with brain
metastases from solid tumors. Methods ASCO convened an Expert Panel and conducted a …
metastases from solid tumors. Methods ASCO convened an Expert Panel and conducted a …
Assessment of risk of xerostomia after whole-brain radiation therapy and association with parotid dose
Importance Whole-brain radiation therapy (WBRT) delivers a substantial radiation dose to
the parotid glands, but the parotid glands are not delineated for avoidance and xerostomia …
the parotid glands, but the parotid glands are not delineated for avoidance and xerostomia …
Prospective assessment of patient-reported dry eye syndrome after whole brain radiation
K Wang, R Tobillo, P Mavroidis, R Pappafotis… - International Journal of …, 2019 - Elsevier
Purpose Dry eye is not typically considered a toxicity of whole brain radiation therapy
(WBRT). We analyzed dry eye syndrome as part of a prospective study of patient-reported …
(WBRT). We analyzed dry eye syndrome as part of a prospective study of patient-reported …
NTCP modeling and dose–volume correlations for acute xerostomia and dry eye after whole brain radiation
P Mavroidis, KA Pearlstein, DH Moon, V Xu… - Radiation …, 2021 - Springer
Background Whole brain radiation (WBRT) may lead to acute xerostomia and dry eye from
incidental parotid and lacrimal exposure, respectively. We performed a prospective …
incidental parotid and lacrimal exposure, respectively. We performed a prospective …
Genesis of quality measurements to improve the care delivered to patients with brain metastases
J Silvestre, T Gosse, P Read, R Gentzler… - JCO Oncology …, 2021 - ascopubs.org
PURPOSE: High-value and high-quality health care requires outcome measurements to
inform treatment decisions, but, to our knowledge, no standardized measurements exist to …
inform treatment decisions, but, to our knowledge, no standardized measurements exist to …
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
C Jiang, TJ Kleber, JM Switchenko, MK Khan - Radiation Oncology, 2021 - Springer
Background The management of melanoma with brain metastases (MBM) is increasingly
complex, especially given recent improvements in targeted agents, immunotherapy, and …
complex, especially given recent improvements in targeted agents, immunotherapy, and …
[HTML][HTML] Interrupted time-series analysis of stereotactic radiosurgery for brain metastases before and after the affordable care act
Abstract The 2010 Patient Protection and Affordable Care Act was aimed at reducing
healthcare costs, improving healthcare quality, and expanding health insurance coverage …
healthcare costs, improving healthcare quality, and expanding health insurance coverage …
[PDF][PDF] Interrupted Time-Series for the Evaluation of Affordable Care Act Impact on Stereotactic Radiosurgery for the Treatment of Brain Metastases
Abstract Background: The 2010 Affordable Care Act aimed at reducing healthcare costs,
improving healthcare quality and expanding health insurance coverage among uninsured …
improving healthcare quality and expanding health insurance coverage among uninsured …
[HTML][HTML] Geographic and temporal variations in the utilization of stereotactic radiosurgery for treatment of non-small cell lung cancer brain metastases from 2010 to …
Purpose This work describes trends in the utilization and survival benefit of stereotactic
radiosurgery (SRS) with respect to geographic region of the United States and year of …
radiosurgery (SRS) with respect to geographic region of the United States and year of …